Li-Wei Kuo, Lyndsey S Crump, Kathleen O'Neill, Michelle M Williams, Jessica L Christenson, Nicole S Spoelstra, Micaela Kalani Roy, Amy Argabright, Julie A Reisz, Angelo D'Alessandro, Meher P Boorgula, Andrew Goodspeed, Mike Bickerdike, Benjamin G Bitler, Jennifer K Richer
{"title":"Blocking Tryptophan Catabolism Reduces Triple-Negative Breast Cancer Invasive Capacity.","authors":"Li-Wei Kuo, Lyndsey S Crump, Kathleen O'Neill, Michelle M Williams, Jessica L Christenson, Nicole S Spoelstra, Micaela Kalani Roy, Amy Argabright, Julie A Reisz, Angelo D'Alessandro, Meher P Boorgula, Andrew Goodspeed, Mike Bickerdike, Benjamin G Bitler, Jennifer K Richer","doi":"10.1158/2767-9764.CRC-24-0272","DOIUrl":null,"url":null,"abstract":"<p><strong>Significance: </strong>TDO2 is more highly expressed than the nonhomologous TRP-catabolizing enzyme IDO1 in TNBC. We find that TDO2 knockdown can lead to a compensatory increase in IDO1. Therefore, we tested a newly developed TDO2/IDO1 dual inhibitor and found that it decreases TRP catabolism, anchorage-independent survival, and invasive capacity.</p>","PeriodicalId":72516,"journal":{"name":"Cancer research communications","volume":" ","pages":"2699-2713"},"PeriodicalIF":2.0000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11484926/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer research communications","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1158/2767-9764.CRC-24-0272","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Significance: TDO2 is more highly expressed than the nonhomologous TRP-catabolizing enzyme IDO1 in TNBC. We find that TDO2 knockdown can lead to a compensatory increase in IDO1. Therefore, we tested a newly developed TDO2/IDO1 dual inhibitor and found that it decreases TRP catabolism, anchorage-independent survival, and invasive capacity.